Daily dose of aspirin ‘increases your chances of getting pregnant by a THIRD’
Women with the inflammatory protein who took a daily aspirin were 31 percent more likely to become pregnant than those who did not take the painkiller
TAKING a low dose of aspirin per day could boost some women's chance of getting pregnant.
Women who had previously suffered a miscarriage or still birth had an elevated level of inflammatory proteins in the body, a new study found.
But experts discovered aspirin can counteract that inflammation by targeting the protein.
Research found that the lowest birthrate occurred in women with the highest amount of the protein, called hsCRP, with just 44 per cent giving birth.
But, out of those women, those who were given a low dose of aspirin had a 59 per cent chance of carrying a baby to term - 15 per cent higher than those who didn't.
Among these women, those who took a daily aspirin were 31 per cent more likely to become pregnant than those who took a placebo, according to
Scientists already knew that inflammatory diseases can cause infertility or complications during pregnancy.
For example, women who have had pelvic inflammatory disease are more like to be infertile.
Researchers examined data on more than 1,200 women in the US who had previously experienced a miscarriage or still birth.
The women were randomly assigned to take either a low dose of common painkiller aspirin or a placebo for six menstrual cycles while trying to become pregnant.
The anti-inflammatory properties of aspirin have been well established, with past studies suggesting it could be used to prevent cancers and heart disease.
RELATED STORIES
But there has long been conflicting advice on the long-term impact of taking aspirin daily which may stop people taking it.
In an earlier analysis of this same study, published in 2014, researchers did not find a link between taking aspirin and a reduced risk of pregnancy loss.
Scientists concluded that the new findings show "low dose aspirin may increase clinical pregnancy and live birth rates to those of women without inflammation and reduce hsCRP elevation during pregnancy.";
The analysis was published in the Journal of Clinical Endocrinology and Metabolism.
We pay for your stories! Do you have a story for The Sun Online news team? Email us at [email protected] or call 0207 782 4368